| Document Date: 2012-03-27 13:54:53
Open Document File Size: 210,12 KBShare Result on Facebook
City Reference / / Event Product Issues / / IndustryTerm magnetic resonance imaging / treatment of cancer / dark blue aqueous solution / chemical name / treatment of acute nonlymphocytic leukemia / / MedicalCondition locally advanced disease / Congestive heart failure / cancer / nasopharyngeal carcinoma / progressive relapsing multiple sclerosis / disease / secondary acute myeloid leukemia / severe hepatic dysfunction / Severe injury / malignant lymphoma / neutropenia / Secondary Leukemia / cardiovascular disease / pain / relapsing-remitting multiple sclerosis / multiple sclerosis / stable disease / infection / MS / Hormone-Refractory Prostate Cancer A / hormone-refractory prostate cancer / breast cancer / acute nonlymphocytic leukemia / / MedicalTreatment hormonal therapy / chemotherapy / radiotherapy / intravenous infusion / / Organization DOSAGE AND ADMINISTRATION / WARNINGS / / Position MP / physician / treating physician / relapses MP / p-value MP / General / / Product methylprednisolone / NOVANTRONE / phenytoin / prednisolone / sodium chloride / testosterone / acetic acid / prednisone / sodium acetate / mitoXANTRONE / MUST BE DILUTED PRIOR TO INJECTION / DNA / / ProvinceOrState Mississippi / / Technology alpha / Pharmacokinetics / artificial intelligence / magnetic resonance imaging / chemotherapy / MRI / /
SocialTag |
NOVANTRONE mitoXANTRONE for injection concentrate WARNING NOVANTRONE (mitoxantrone for injection concentrate) should be administered under the supervision of a physician experienced in the use of cytotoxic chemothe